2025 H2 -tulosraportti
169 päivää sitten
‧38 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 | ||
2023 H2 -tulosraportti 28.2.2024 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
5 t sittenhttps://medwatch.no/nyheter/debatt/article19540984.ece?utm_campaign=MedWatch&utm_content=2026-08-14&utm_medium=email&utm_source=medwatch_no The Biotechnology Act represents a massive regulatory victory for the radioligand therapy (RLT) sector. It eliminates the two biggest bottlenecks (dual licensing and individualized dosing), harmonizes EU regulations, and enables faster, more cost-effective, and more competitive radiopharmaceutical development.
·11 t sitten · MuokattuFinally ready for closing the gap at 6.10 as previously mentioned, expecting a move upwards for the rest of the day :-). Should be a good entry point for those who haven't joined yet☝️
I am waiting for more information. Whether it stands at 5.80 or 6.50 when that day comes does not affect that assessment much.- ·13 t sittenMuch positive and exciting around the company currently. Some talk about 8 kr, others about 13 kr etc. That becomes a bit too speculative for my taste. But, please convince me with mathematics and preferably some sentences. PS! AM NOT NEGATIVE..
Well.. selling out now is in a way lucrative but not life-changing. If we get blue sky with both alphaone and management speeding up a2 due to demand from advancell and other partners, that would have been fantastic, and I must say Thor is really pushing it. Ruining a low GAV for "small money" and paying around 38% tax means I'm holding at least. If the demand is really so great for alpha emitters, must Thor be perfect for an acquisition? Not that I want that, I'd rather they keep grinding on a1, get more contracts and then report escalation. Things can still go wrong but I really have faith, I must say. Anyway, we are here to make money and my tactic is loooong. Happy weekend everyone🍻 ps. Try not to panic sell and lose money on stop-loss when algorithms start working on low volume and snatch your shares😉 
·14 t sittenRisk that stop loss will be put to the test today.. Crossing my fingers...
Thor Medical is holding strong today. Already 1.1 million shares have changed hands, so it is clear that some larger players are trading in the market. The stock still shows good interest and is holding up well after the strong rally recently.- ·1 päivä sitten · MuokattuI think Thor has been incredibly strong today considering that we have risen almost 50% in the last 14 days. Normally we would have had a good dip back but I think the expectations are simply too high and too many want to get in for us to fall significantly back. This will be fantastic in the long term😍
Many good comments here. But you are right anyway, Thor is strong as F for the time being. Enjoying this journey to the fullest after the Nano-fuzz long time ago.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H2 -tulosraportti
169 päivää sitten
‧38 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- 5 t sittenhttps://medwatch.no/nyheter/debatt/article19540984.ece?utm_campaign=MedWatch&utm_content=2026-08-14&utm_medium=email&utm_source=medwatch_no The Biotechnology Act represents a massive regulatory victory for the radioligand therapy (RLT) sector. It eliminates the two biggest bottlenecks (dual licensing and individualized dosing), harmonizes EU regulations, and enables faster, more cost-effective, and more competitive radiopharmaceutical development.
- ·11 t sitten · MuokattuFinally ready for closing the gap at 6.10 as previously mentioned, expecting a move upwards for the rest of the day :-). Should be a good entry point for those who haven't joined yet☝️I am waiting for more information. Whether it stands at 5.80 or 6.50 when that day comes does not affect that assessment much.
- ·13 t sittenMuch positive and exciting around the company currently. Some talk about 8 kr, others about 13 kr etc. That becomes a bit too speculative for my taste. But, please convince me with mathematics and preferably some sentences. PS! AM NOT NEGATIVE..Well.. selling out now is in a way lucrative but not life-changing. If we get blue sky with both alphaone and management speeding up a2 due to demand from advancell and other partners, that would have been fantastic, and I must say Thor is really pushing it. Ruining a low GAV for "small money" and paying around 38% tax means I'm holding at least. If the demand is really so great for alpha emitters, must Thor be perfect for an acquisition? Not that I want that, I'd rather they keep grinding on a1, get more contracts and then report escalation. Things can still go wrong but I really have faith, I must say. Anyway, we are here to make money and my tactic is loooong. Happy weekend everyone🍻 ps. Try not to panic sell and lose money on stop-loss when algorithms start working on low volume and snatch your shares😉
- ·14 t sittenRisk that stop loss will be put to the test today.. Crossing my fingers...Thor Medical is holding strong today. Already 1.1 million shares have changed hands, so it is clear that some larger players are trading in the market. The stock still shows good interest and is holding up well after the strong rally recently.
- ·1 päivä sitten · MuokattuI think Thor has been incredibly strong today considering that we have risen almost 50% in the last 14 days. Normally we would have had a good dip back but I think the expectations are simply too high and too many want to get in for us to fall significantly back. This will be fantastic in the long term😍Many good comments here. But you are right anyway, Thor is strong as F for the time being. Enjoying this journey to the fullest after the Nano-fuzz long time ago.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 | ||
2023 H2 -tulosraportti 28.2.2024 |
2025 H2 -tulosraportti
169 päivää sitten
‧38 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 | ||
2023 H2 -tulosraportti 28.2.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- 5 t sittenhttps://medwatch.no/nyheter/debatt/article19540984.ece?utm_campaign=MedWatch&utm_content=2026-08-14&utm_medium=email&utm_source=medwatch_no The Biotechnology Act represents a massive regulatory victory for the radioligand therapy (RLT) sector. It eliminates the two biggest bottlenecks (dual licensing and individualized dosing), harmonizes EU regulations, and enables faster, more cost-effective, and more competitive radiopharmaceutical development.
- ·11 t sitten · MuokattuFinally ready for closing the gap at 6.10 as previously mentioned, expecting a move upwards for the rest of the day :-). Should be a good entry point for those who haven't joined yet☝️I am waiting for more information. Whether it stands at 5.80 or 6.50 when that day comes does not affect that assessment much.
- ·13 t sittenMuch positive and exciting around the company currently. Some talk about 8 kr, others about 13 kr etc. That becomes a bit too speculative for my taste. But, please convince me with mathematics and preferably some sentences. PS! AM NOT NEGATIVE..Well.. selling out now is in a way lucrative but not life-changing. If we get blue sky with both alphaone and management speeding up a2 due to demand from advancell and other partners, that would have been fantastic, and I must say Thor is really pushing it. Ruining a low GAV for "small money" and paying around 38% tax means I'm holding at least. If the demand is really so great for alpha emitters, must Thor be perfect for an acquisition? Not that I want that, I'd rather they keep grinding on a1, get more contracts and then report escalation. Things can still go wrong but I really have faith, I must say. Anyway, we are here to make money and my tactic is loooong. Happy weekend everyone🍻 ps. Try not to panic sell and lose money on stop-loss when algorithms start working on low volume and snatch your shares😉
- ·14 t sittenRisk that stop loss will be put to the test today.. Crossing my fingers...Thor Medical is holding strong today. Already 1.1 million shares have changed hands, so it is clear that some larger players are trading in the market. The stock still shows good interest and is holding up well after the strong rally recently.
- ·1 päivä sitten · MuokattuI think Thor has been incredibly strong today considering that we have risen almost 50% in the last 14 days. Normally we would have had a good dip back but I think the expectations are simply too high and too many want to get in for us to fall significantly back. This will be fantastic in the long term😍Many good comments here. But you are right anyway, Thor is strong as F for the time being. Enjoying this journey to the fullest after the Nano-fuzz long time ago.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt